In a report released on December 23, Oliver Reinberg from Kepler Capital maintained a Hold rating on STRATEC Biomedical (0RAR – Research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback